[1]
Shonukan, O., Dantzig, A., Kloeker-Rhoades, S. and Garcia-Ribas, I. 2009. Development of LY2334737, an oral gemcitabine prodrug for continuous administration. Perspectives for the therapy of mature T-cell and NK-cell lymphomas. Hematology Meeting Reports (formerly Haematologica Reports). 3, 1 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i1.533.